Toggle light / dark theme

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics

Researchers at Weill Cornell Medicine have uncovered how a key Parkinson’s protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state. Mutations that cause LRRK2 to become abnormally active are among the most common genetic causes of Parkinson’s disease. Even without these mutations, some people with Parkinson’s disease have elevated LRRK2 activity.

Understanding exactly how LRRK2 becomes overactive has become increasingly important because it is one of the leading targets for developing treatments that could slow Parkinson’s disease.

Using electron microscopy and biochemistry, the team captured the structure of LRRK2 in different states, enabling them to elucidate how the protein toggles between active and inactive forms. The findings, published in Cell, point toward a new generation of targeted therapies.

2 Comments so far

  1. My husband thought I was having a stroke nope several years later MSA-C in Dec 2024 i couldn’t walk because of dizziness shake couldn’t drive or sign my name, I was on 5.5 levodopa to help with increased rigidity that was causing severe joint pain. I was also on Vit D, B12 but that didn’t help much and worsened my edema.. my neurologist took me off all meds as they weren’t working and suggested we try alternative treatments, so last August, our family doctor started me on the MSA-5 protocol—the best decision ever! 4 months into treatment and my symptoms improved. My muscle weakness has improved and i can now walk down the street and back, the Dizziness are gone, my sleep pattern has also returned to normal and i have become very active. Visit Limitlessnaturalwellness. com for the MSA-5 protocol, for me i would say this is a breakthrough for people with Multiple System Atrophy

  2. My 68 year old Husband who suffered from muscle tiredness brought on by chronic fatigue in its early stages. Neurologists first had difficulty diagnosing it until multiple examinations indicated MSA, for which there was no known cure other than the prescription of levodopa medications, vitamins, and therapies. More advancements in breathing difficulties, before we made the decision to try different medications, which significantly enhanced his condition. He received MSA-5 treatment for MSA at Limitlessnaturalwellness. com from the U.S approximately four months ago; since then, he sleeps well, works out frequently, and has become very active. it has improved his quality of life. .

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.